Natco Pharma Q4 Results

  • BSE: 524816
  • NSE: NATCOPHARM
  • ISIN: INE987B01026
  • Sector: Biotechnology & Drugs
BSE
1,369.213.20 (0.97%)
Volume17.41 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,364.957.35 (0.54%)
Volume5.72 L
Updated: Mon 25 Nov, 2024 | 15:43:45
Today: 1,355.45
1,383.50
52-Wk: 752.55
1,638.35

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Natco Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 1,068.30492.50-%897.90-%
    Selling/ General/ Admin Expenses Total 142.50105.60-%118.90-%
    Depreciation/ Amortization 55.5041.50-%41.00-%
    Other Operating Expenses Total 285.90165.60-%181.50-%
    Total Operating Expense 626.50428.10-%599.80-%
    Operating Income 441.8064.40-%298.10-%
    Net Income Before Taxes 477.6081.40-%324.40-%
    Net Income 386.3062.30-%275.80-%
    Diluted Normalized EPS 21.563.41-%15.10-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts